Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652.

[1]  Henry J. Duff,et al.  Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37°C and 42°C , 2005 .

[2]  Michael C Sanguinetti,et al.  Predicting drug-hERG channel interactions that cause acquired long QT syndrome. , 2005, Trends in pharmacological sciences.

[3]  Jules C Hancox,et al.  High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656. , 2004, Biochemical and biophysical research communications.

[4]  Jules C Hancox,et al.  The Low-Potency, Voltage-Dependent HERG Blocker Propafenone—Molecular Determinants and Drug Trapping , 2004, Molecular Pharmacology.

[5]  A. Brown,et al.  Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern. , 2004, Journal of pharmacological and toxicological methods.

[6]  B. Wible,et al.  Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action , 2004, British Journal of Pharmacology.

[7]  J. Hancox,et al.  Lidoflazine is a high affinity blocker of the HERG K(+)channel. , 2004, Journal of molecular and cellular cardiology.

[8]  Hugo A. Katus,et al.  Inhibition of human ether-a-go-go-related gene potassium channels by α1-adrenoceptor antagonists prazosin, doxazosin, and terazosin , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  William J. Crumb,et al.  Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel , 2003, Molecular and Cellular Biochemistry.

[10]  J. Hancox,et al.  Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm‐1 scorpion toxin , 2003, FEBS letters.

[11]  J. Hancox,et al.  Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652 , 2003, British journal of pharmacology.

[12]  E. Grishin,et al.  BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1. , 2003, Biophysical journal.

[13]  Jun Zhou,et al.  Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. , 2002, The Journal of pharmacology and experimental therapeutics.

[14]  I Kodama,et al.  Open channel block of HERG K(+) channels by vesnarinone. , 2001, Molecular pharmacology.

[15]  Gea-Ny Tseng,et al.  IKr: The hERG Channel , 2001 .

[16]  T J Campbell,et al.  HERG K+ channels: friend and foe. , 2001, Trends in pharmacological sciences.

[17]  Jun Chen,et al.  A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Friedman,et al.  The effects of erythromycin on the electrocardiogram. , 1999, Chest.

[19]  C. January,et al.  Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. , 1998, Biophysical journal.

[20]  G. Stephenson,et al.  Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity. , 1997, Journal of pharmaceutical sciences.

[21]  M. Sanguinetti,et al.  Role of delayed rectifier potassium channels in cardiac repolarization and arrhythmias , 1997 .

[22]  B. Wallace,et al.  HOLE: a program for the analysis of the pore dimensions of ion channel structural models. , 1996, Journal of molecular graphics.